Evidence map›Paper›PMID 34188164›Full record

ArticleMolecular psychiatry2021

Disruption of NEUROD2 causes a neurodevelopmental syndrome with autistic features via cell-autonomous defects in forebrain glutamatergic neurons.

Karen Runge, Rémi Mathieu, Stéphane Bugeon, Sahra Lafi, Corinne Beurrier, Surajit Sahu, Fabienne Schaller, Arthur Loubat, Leonard Herault, Stéphane Gaillard and 28 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Molecular psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Neurod2 knockdown inmicroPublication biology · 2026
    Article
  6. Temporal Transcriptional Regulation of Human Neuronal Differentiation via Forward Programming.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  7. Dissecting Gene Regulatory Networks Governing Human Cortical Cell Fate.bioRxiv : the preprint server for biology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

38 authors at 16 institutions in 7 countries.

Karen Runge *INMED, INSERM, Aix-Marseille University, Marseille, France.
Rémi Mathieu *INMED, INSERM, Aix-Marseille University, Marseille, France.
Stéphane Bugeon *IBDM, Aix-Marseille University, CNRS, UMR, Marseille, France.
Sahra LafiINMED, INSERM, Aix-Marseille University, Marseille, France.
Corinne BeurrierIBDM, Aix-Marseille University, CNRS, UMR, Marseille, France.
Surajit SahuINMED, INSERM, Aix-Marseille University, Marseille, France.
Fabienne SchallerINMED, INSERM, Aix-Marseille University, Marseille, France.
Arthur LoubatINMED, INSERM, Aix-Marseille University, Marseille, France.
Leonard HeraultTAGC INSERM U1090, Aix-Marseille University, Marseille, France.
Stéphane GaillardPhenotype Expertise, 5 Boulevard du Maréchal Koenig, Marseille, France.
Emilie Pallesi-PocachardINMED, INSERM, Aix-Marseille University, Marseille, France.
Aurélie MontheilINMED, INSERM, Aix-Marseille University, Marseille, France.
Andreas BosioMiltenyi Biotec, Bergisch-Gladbach, Germany.
Jill A RosenfeldBaylor College of Medicine, Houston, TX, USA.ORCID http://orcid.org/0000-0001-5664-7987
Eva HudsonCook Children's Clinical Genetics, Fort Worth, TX, USA.
Kristin LindstromDivision of genetics and Metabolism, Phoenix Children's Hospital, Phoenix, AZ, USA.
Saadet Mercimek-AndrewsDepartment of Medical Genetics, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB, Canada.
Lauren JeffriesPediatric Genomics Discovery Program, Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA.
Arie van HaeringenDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands.
Olivier VanakkerCenter for Medical Genetics, Department of Biomolecular Medicine, Ghent University and Ghent University Hospital, Ghent, Belgium.
Audrey Van HeckeDepartment of Neurology, Queen Fabiola Children's University Hospital, Brussels, Belgium.
Dina AmromDepartment of Neurology, Queen Fabiola Children's University Hospital, Brussels, Belgium.
Sebastien KüryCentre Hospitalier Universitaire de Nantes, Service de Génétique Médicale, Nantes, France.
Chana RatnerHackensack University Medical Center, Hackensack, NJ, USA.
Reena JethvaHackensack University Medical Center, Hackensack, NJ, USA.
Candace GambleCook Children's Clinical Genetics, Fort Worth, TX, USA.
Bernard JacqIBDM, Aix-Marseille University, CNRS, UMR, Marseille, France.
Laurent FasanoIBDM, Aix-Marseille University, CNRS, UMR, Marseille, France.
Gabriel SantpereDepartment of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-5909-8637
Belen Lorente-GaldosDepartment of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT, USA.
Nenad SestanDepartment of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-0966-9619
Antoinette GelotTrousseau Hospital, Paris, France.
Sylvie GiacuzzTrousseau Hospital, Paris, France.
Sandra GoebbelsMax-Planck-Institute of Experimental Medicine, Goettingen, Germany.
Alfonso RepresaINMED, INSERM, Aix-Marseille University, Marseille, France.
Carlos Cardoso *INMED, INSERM, Aix-Marseille University, Marseille, France.ORCID http://orcid.org/0000-0003-1914-9553
Harold Cremer *IBDM, Aix-Marseille University, CNRS, UMR, Marseille, France.
Antoine de ChevignyINMED, INSERM, Aix-Marseille University, Marseille, France. antoine.de-chevigny@inserm.fr.ORCID http://orcid.org/0000-0002-7413-0591
Inserm · FRCentre National de la Recherche Scientifique · FRYale University · USHackensack University Medical Center · USUniversité Libre de Bruxelles · BEUniversity of North Texas · USAix-Marseille Université · FRBaylor College of Medicine · USDélégation Provence et Corse · FRGhent University Hospital · BELeiden University Medical Center · NLMax Planck Institute of Experimental Medicine · DEMiltenyi Biotec (Germany) · DEPhoenix Children's Hospital · USSorbonne Université · FRUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While the transcription factor NEUROD2 has recently been associated with epilepsy, its precise role during nervous system development remains unclear. Using a multi-scale approach, we set out to understand how Neurod2 deletion affects the development of the cerebral cortex in mice. In Neurod2 KO embryos, cortical projection neurons over-migrated, thereby altering the final size and position of layers. In juvenile and adults, spine density and turnover were dysregulated in apical but not basal compartments in layer 5 neurons. Patch-clamp recordings in layer 5 neurons of juvenile mice revealed increased intrinsic excitability. Bulk RNA sequencing showed dysregulated expression of many genes associated with neuronal excitability and synaptic function, whose human orthologs were strongly associated with autism spectrum disorders (ASD). At the behavior level, Neurod2 KO mice displayed social interaction deficits, stereotypies, hyperactivity, and occasionally spontaneous seizures. Mice heterozygous for Neurod2 had similar defects, indicating that Neurod2 is haploinsufficient. Finally, specific deletion of Neurod2 in forebrain excitatory neurons recapitulated cellular and behavioral phenotypes found in constitutive KO mice, revealing the region-specific contribution of dysfunctional Neurod2 in symptoms. Informed by these neurobehavioral features in mouse mutants, we identified eleven patients from eight families with a neurodevelopmental disorder including intellectual disability and ASD associated with NEUROD2 pathogenic mutations. Our findings demonstrate crucial roles for Neurod2 in neocortical development, whose alterations can cause neurodevelopmental disorders including intellectual disability and ASD.

Indexed as

Autistic DisorderNeuropeptidesAnimalsBasic Helix-Loop-Helix ProteinsCerebral CortexHumansMiceNeuronsProsencephalonTranscription FactorsBasic Helix-Loop-Helix ProteinsNEUROD2 protein, humanNeurod2 protein, mouseNeuropeptidesTranscription Factors

Identifiers

PMID34188164
PMCPMC8760061
OpenAlexW3175688392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.